Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10329065rdf:typepubmed:Citationlld:pubmed
pubmed-article:10329065lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10329065lifeskim:mentionsumls-concept:C1706169lld:lifeskim
pubmed-article:10329065lifeskim:mentionsumls-concept:C0005821lld:lifeskim
pubmed-article:10329065lifeskim:mentionsumls-concept:C0007222lld:lifeskim
pubmed-article:10329065lifeskim:mentionsumls-concept:C0017968lld:lifeskim
pubmed-article:10329065lifeskim:mentionsumls-concept:C0016006lld:lifeskim
pubmed-article:10329065lifeskim:mentionsumls-concept:C0031667lld:lifeskim
pubmed-article:10329065lifeskim:mentionsumls-concept:C1446409lld:lifeskim
pubmed-article:10329065lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:10329065lifeskim:mentionsumls-concept:C1418617lld:lifeskim
pubmed-article:10329065lifeskim:mentionsumls-concept:C1706170lld:lifeskim
pubmed-article:10329065lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:10329065pubmed:issue10lld:pubmed
pubmed-article:10329065pubmed:dateCreated1999-7-8lld:pubmed
pubmed-article:10329065pubmed:abstractTextThe GPIIb-IIIa complex on the platelet membrane plays an important part in thrombosis as it is the receptor for fibrinogen. The gene for platelet membrane glyco-protein IIIa has multiple alleles one of which, the GPIIIa-Proline33 (HPA-1b, PlA2, Zwb) allele has been reported in some, but not all studies, to be associated with an increased risk of myocardial infarction. We investigated whether the presence of the Pro33 form of GPIIIa on the platelet membrane is associated with increased fibrinogen binding.lld:pubmed
pubmed-article:10329065pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10329065pubmed:languageenglld:pubmed
pubmed-article:10329065pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10329065pubmed:citationSubsetIMlld:pubmed
pubmed-article:10329065pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10329065pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10329065pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10329065pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10329065pubmed:statusMEDLINElld:pubmed
pubmed-article:10329065pubmed:monthMaylld:pubmed
pubmed-article:10329065pubmed:issn0195-668Xlld:pubmed
pubmed-article:10329065pubmed:authorpubmed-author:OokT HTHlld:pubmed
pubmed-article:10329065pubmed:authorpubmed-author:GoodallA HAHlld:pubmed
pubmed-article:10329065pubmed:authorpubmed-author:KnightC JCJlld:pubmed
pubmed-article:10329065pubmed:authorpubmed-author:HurdCClld:pubmed
pubmed-article:10329065pubmed:authorpubmed-author:CurzenNNlld:pubmed
pubmed-article:10329065pubmed:authorpubmed-author:OuwehandW HWHlld:pubmed
pubmed-article:10329065pubmed:authorpubmed-author:PanesarMMlld:pubmed
pubmed-article:10329065pubmed:copyrightInfoCopyright 1999 The European Society of Cardiology.lld:pubmed
pubmed-article:10329065pubmed:issnTypePrintlld:pubmed
pubmed-article:10329065pubmed:volume20lld:pubmed
pubmed-article:10329065pubmed:ownerNLMlld:pubmed
pubmed-article:10329065pubmed:authorsCompleteYlld:pubmed
pubmed-article:10329065pubmed:pagination742-7lld:pubmed
pubmed-article:10329065pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10329065pubmed:meshHeadingpubmed-meshheading:10329065...lld:pubmed
pubmed-article:10329065pubmed:meshHeadingpubmed-meshheading:10329065...lld:pubmed
pubmed-article:10329065pubmed:meshHeadingpubmed-meshheading:10329065...lld:pubmed
pubmed-article:10329065pubmed:meshHeadingpubmed-meshheading:10329065...lld:pubmed
pubmed-article:10329065pubmed:meshHeadingpubmed-meshheading:10329065...lld:pubmed
pubmed-article:10329065pubmed:meshHeadingpubmed-meshheading:10329065...lld:pubmed
pubmed-article:10329065pubmed:meshHeadingpubmed-meshheading:10329065...lld:pubmed
pubmed-article:10329065pubmed:meshHeadingpubmed-meshheading:10329065...lld:pubmed
pubmed-article:10329065pubmed:meshHeadingpubmed-meshheading:10329065...lld:pubmed
pubmed-article:10329065pubmed:meshHeadingpubmed-meshheading:10329065...lld:pubmed
pubmed-article:10329065pubmed:meshHeadingpubmed-meshheading:10329065...lld:pubmed
pubmed-article:10329065pubmed:meshHeadingpubmed-meshheading:10329065...lld:pubmed
pubmed-article:10329065pubmed:meshHeadingpubmed-meshheading:10329065...lld:pubmed
pubmed-article:10329065pubmed:meshHeadingpubmed-meshheading:10329065...lld:pubmed
pubmed-article:10329065pubmed:meshHeadingpubmed-meshheading:10329065...lld:pubmed
pubmed-article:10329065pubmed:year1999lld:pubmed
pubmed-article:10329065pubmed:articleTitleIncreased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease.lld:pubmed
pubmed-article:10329065pubmed:affiliationDivision of Chemical Pathology, University of Leicester, Glenfield Hospital, UK.lld:pubmed
pubmed-article:10329065pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10329065pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10329065lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10329065lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10329065lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10329065lld:pubmed